Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies
Phytotherapy Research · 2025-05 · 39 (5) · 1966-1995
DOI: 10.1002/ptr.8454 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 18.02.2025. Verfasst von Meenal Sahu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience & Biotechnology, Banasthali Vidyapith, Banasthali, Rajasthan, India. Hauptthemen laut MEDLINE: Triterpenes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 161 Literaturangaben.
Abstract (Originalsprache)
The most prevalent and bioactive cucurbitacin is Cucurbitacin B (CuB, C 32 H 46 O 8 ), which is a tetracyclic triterpene chiefly present in the Cucurbitaceae family. CuB has a wide spectrum of pharmacological properties namely antioxidant, anticancer, hepatoprotective, anti‐inflammatory, antiviral, hypoglycaemic, insecticidal, and neuroprotective properties, owing to its ability to regulate several signaling pathways, including the Janus kinase/signal transducer and activator of transcription‐3 (JAK/STAT3), AMP‐activated protein kinase (AMPK), nuclear factor (NF)‐κB, nuclear factor erythroid 2‐related factor‐2/antioxidant responsive element (Nrf2/ARE), phosphoinositide 3‐kinase (PI3K)/Akt, mitogen‐activated protein kinase (MAPK), Hippo‐Yes‐associated protein (YAP), focal adhesion kinase (FAK), cancerous inhibitor of protein phosphatase‐2A/protein phosphatase‐2A (CIP2A/PP2A), Wnt and Notch pathways. The present review highlights the medicinal attributes of Cucurbitacin B (CuB) with special emphasis on their signaling pathways to provide key evidence of its therapeutic utility in the near future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioscience & Biotechnology, Banasthali Vidyapith, Banasthali, Rajasthan, India.
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
- Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan, India.
- Department of Internal Medicine, Division of Cardiology, LSU Health Sciences Center, Shreveport, Louisiana, USA.
- Department of Chemistry, Banasthali Vidyapith, Banasthali, Rajasthan, India.
ORCID-Profile: Jaya Dwivedi, Swapnil Sharma
Zitieren
APA
Sahu, M., Paliwal, T., Jain, S., Verma, K., Chakraborty, D., Jaiswal, S., Dwivedi, J., & Sharma, S. (2025). Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies. Phytotherapy Research, 39(5), 1966-1995. https://doi.org/10.1002/ptr.8454
Vancouver
Sahu M, Paliwal T, Jain S, Verma K, Chakraborty D, Jaiswal S, et al. Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies. Phytotherapy Research. 2025;39(5):1966-1995. doi:10.1002/ptr.8454
BibTeX
@article{Sahu2025,
author = {Sahu, Meenal and Paliwal, Tripti and Jain, Smita and Verma, Kanika and Chakraborty, Dipjyoti and Jaiswal, Shivangi and Dwivedi, Jaya and Sharma, Swapnil},
title = {Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {5},
pages = {1966--1995},
doi = {10.1002/ptr.8454}
}
EUVIMED